Hymeglusin
Hymeglusin is a selective HMG-CoA synthase 1 inhibitor with antibiotic properties. It downregulates BCL2 expression in leukemia cell lines like HL-60 and KG-1, making it a useful compound for studying oncogenesis and potential therapeutic strategies in hematological cancers.
Product Specifications
CAS Number
29066-42-0
Product Name Alternative
L-659699; Antibiotic 1233A; Antibiotic F244
Field of Research
Infectious Disease & Virology
Purity
>98%
Bioactivity
Mevalonate biosynthesis inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to 25 mg/ml)
Smiles
C (O) [C@@H]1[C@@H] (CCCC[C@H] (C/C (=C/C (=C/C (O) =O) /C) /C) C) OC1=O
Molecular Formula
C18H28O5
Molecular Weight
324.41
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
11-[3R- (Hydroxymethyl) -4-oxo-2R-oxetanyl]-3,5,7R-trimethyl-2E,4E-undecadienoic acid
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0809506 1.0 µg DNA
FRA13C sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
Sign In for Pricing
View Details IC361G-100UG 100 µg
Human CCL19/MIP-3 beta Alexa Fluor 488 Antibody
Sign In for Pricing
View Details 
LV812131 1.0 µg DNA
LOC554206 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)
Sign In for Pricing
View Details MBS1136128 Inquire
Recombinant Cupriavidus taiwanensis Probable intracellular septation protein A (RALTA_A1457)
Sign In for Pricing
View Details 